The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if you have naphthyl D you are very likely insulin resistant right if you are insulin resistant you are up regulating a possi 3 if you are up regulating a possi 3 you're VLDL are going to stick around a hell of a lot longer than if you do not and that's why we see these pathologic remnant v LDL particles that become atherogenic
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.